Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Muhleisen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Drug and Alcohol Review|December 9, 2003
Crushing buprenorphine tabletsPeter Muhleisen, James Spence, Suzi Nielsen
Substance Abuse|November 20, 2002
Training primary health care professionals to provide buprenorphine and LAAM treatmentNicholas Lintzeris, Alison Ritter, Adrian Dunlop, et al.
Drug and Alcohol Review|March 17, 2007
Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identifiedSuzanne Nielsen, Paul Dietze, Adrian Dunlop, et al.
Drug and Alcohol Review|December 30, 2014
Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case seriesSuzanne Nielsen, Bridin Murnion, Adrian Dunlop, et al.
Drug and Alcohol Review|July 31, 2015
Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, AustraliaSuzanne Nielsen, Raimondo Bruno, Bridin Murnion, et al.
JAMA Psychiatry|January 17, 2014
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trialDavid J Allsop, Jan Copeland, Nicholas Lintzeris, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Drug and Alcohol Review|December 9, 2003
Crushing buprenorphine tabletsPeter Muhleisen, James Spence, Suzi Nielsen
Substance Abuse|November 20, 2002
Training primary health care professionals to provide buprenorphine and LAAM treatmentNicholas Lintzeris, Alison Ritter, Adrian Dunlop, et al.
Drug and Alcohol Review|March 17, 2007
Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identifiedSuzanne Nielsen, Paul Dietze, Adrian Dunlop, et al.
Drug and Alcohol Review|December 30, 2014
Comparing treatment-seeking codeine users and strong opioid users: Findings from a novel case seriesSuzanne Nielsen, Bridin Murnion, Adrian Dunlop, et al.
Drug and Alcohol Review|July 31, 2015
Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, AustraliaSuzanne Nielsen, Raimondo Bruno, Bridin Murnion, et al.
JAMA Psychiatry|January 17, 2014
Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trialDavid J Allsop, Jan Copeland, Nicholas Lintzeris, et al.
Pageof 1